Tuan Tu Diep insider trades

Open-market stock purchases and sales by Tuan Tu Diep, Chief Operating Officer at Skye Bioscience, Inc, from SEC Form 4 filings since Feb 29, 2024.

Recent trades

DateStockTradeValue
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$92.3K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$434K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$5.7K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$32.2K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$13.5K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$77.1K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$76.9K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$644K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$4.9K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$90K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$4.4K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$103K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$46.1K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$1.1M
Feb 6, 2026SKYE Skye Bioscience, IncBought (not open market)—

Companies traded

  • SKYE Skye Bioscience, Inc: 2 sales, last Mar 31, 2026

Get free alerts when Tuan Tu Diep files a new trade →